CFTZV Financials
This page shows CFTZV (CFTZV) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
An asset-heavy, debt-funded model keeps operating cash flow positive, but depreciation and interest keep the assets from earning their keep.
Over the past five years, revenue nearly tripled and operating cash flow stayed positive, yet losses persisted because depreciation and interest reached roughly$65.5M in FY2025. That mix explains why reported profit looks weak even though cash arrives: the business throws off cash before the full cost of carrying a very large asset base shows up in earnings, which points to a capital-intensive structure rather than a simple demand problem.
Leverage has become the main constraint: liabilities reached
Capital returns continued despite losses, and shares outstanding fell by roughly a quarter over the last couple of years. At the same time, equity dropped to
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of CFTZV's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
CFTZV's revenue grew a modest 2.4% year-over-year to $97.9M. This slow but positive growth earns a score of 40/100.
CFTZV has a moderate D/E ratio of 3.53. This balance of debt and equity financing earns a leverage score of 30/100.
CFTZV generates a -5.0% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 2/100. This is down from -4.0% the prior year.
CFTZV passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, CFTZV generates $-3.25 in operating cash flow ($27.4M OCF vs -$8.4M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Key Financial Metrics
Earnings & Revenue
CFTZV generated $97.9M in revenue in fiscal year 2025. This represents an increase of 2.4% from the prior year.
CFTZV reported -$8.4M in net income in fiscal year 2025. This represents an increase of 7.9% from the prior year.
CFTZV earned $-0.70 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 6.1% from the prior year.
Cash & Balance Sheet
CFTZV held $25.4M in cash against $600.7M in long-term debt as of fiscal year 2025.
CFTZV had 11M shares outstanding in fiscal year 2025. This represents a decrease of 11.9% from the prior year.
Margins & Returns
CFTZV's net profit margin was -8.6% in fiscal year 2025, showing the share of revenue converted to profit. This is up 1.0 percentage points from the prior year.
CFTZV's ROE was -5.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 0.9 percentage points from the prior year.
Capital Allocation
CFTZV spent $40.4M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 32.3% from the prior year.
CFTZV Income Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $24.8M+1.5% | $24.4M-2.2% | $25.0M+5.4% | $23.7M+2.2% | $23.2M-1.2% | $23.4M-9.1% | $25.8M+11.4% | $23.1M |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $244K-25.7% | $328K+340.4% | $75K+0.7% | $74K-32.0% | $109K+60.4% | $68K+7.3% | $63K-6.0% | $67K |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | $6.9M-5.7% | $7.3M+2.1% | $7.2M+3.7% | $6.9M-0.7% | $7.0M-2.0% | $7.1M+5.0% | $6.8M+3.4% | $6.5M |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$5.1M-326.4% | -$1.2M+31.1% | -$1.7M-283.5% | -$449K+90.6% | -$4.8M-104.5% | -$2.3M-19.1% | -$2.0M-2304.0% | -$81K |
| EPS (Diluted) | N/A | $-0.10+28.6% | $-0.14-250.0% | $-0.04 | N/A | $-0.17-21.4% | $-0.14-1300.0% | $-0.01 |
CFTZV Balance Sheet
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.1B-1.2% | $1.2B-0.8% | $1.2B-0.2% | $1.2B+3.2% | $1.1B-1.9% | $1.1B+3.0% | $1.1B-1.5% | $1.1B |
| Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $25.4M-14.5% | $29.7M+4.2% | $28.5M+22.4% | $23.3M-35.6% | $36.1M+29.3% | $27.9M+9.7% | $25.5M-9.6% | $28.2M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $966.8M+0.6% | $961.3M+0.7% | $955.0M+0.9% | $946.5M+5.2% | $899.5M-1.1% | $909.8M+6.2% | $856.4M+0.3% | $853.6M |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Debt | $600.7M-1.8% | $611.7M+1.7% | $601.7M+2.3% | $588.2M | N/A | N/A | N/A | N/A |
| Total Equity | $170.0M-10.3% | $189.5M-7.5% | $204.9M-5.1% | $215.8M-4.7% | $226.5M-4.8% | $238.0M-7.6% | $257.7M-7.0% | $276.9M |
| Retained Earnings | -$142.0M-6.7% | -$133.1M-4.5% | -$127.3M-5.3% | -$120.9M-4.5% | -$115.7M-9.2% | -$105.9M-7.6% | -$98.4M-8.0% | -$91.1M |
CFTZV Cash Flow Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.8M+5.3% | $5.5M-24.1% | $7.3M-15.5% | $8.7M-5.8% | $9.2M+29.6% | $7.1M-23.4% | $9.2M+94.3% | $4.8M |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | -$445K+73.6% | -$1.7M+31.1% | -$2.4M+61.4% | -$6.3M-136.5% | $17.4M+1310.4% | -$1.4M-126.2% | $5.5M+68.9% | $3.2M |
| Financing Cash Flow | -$9.6M-66.1% | -$5.8M-4479.8% | $132K+100.9% | -$14.1M+22.2% | -$18.1M-348.0% | -$4.1M+76.6% | -$17.3M-62.1% | -$10.7M |
| Dividends Paid | $3.2M-4.3% | $3.3M-1.8% | $3.4M+0.5% | $3.4M-5.1% | $3.5M-4.6% | $3.7M-6.4% | $4.0M-2.2% | $4.0M |
| Share Buybacks | $11.5M-5.4% | $12.1M+61.7% | $7.5M-19.1% | $9.3M-29.9% | $13.2M-9.7% | $14.6M-6.2% | $15.6M-3.3% | $16.1M |
CFTZV Financial Ratios
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | -20.4%-15.5pp | -4.9%+2.0pp | -6.9%-5.0pp | -1.9%+18.7pp | -20.6%-10.6pp | -9.9%-2.4pp | -7.6%-7.2pp | -0.4% |
| Return on Equity | -3.0%-2.3pp | -0.6%+0.2pp | -0.8%-0.6pp | -0.2%+1.9pp | -2.1%-1.1pp | -1.0%-0.2pp | -0.8%-0.7pp | -0.0% |
| Return on Assets | -0.4%-0.3pp | -0.1%+0.1pp | -0.1%-0.1pp | -0.0%+0.4pp | -0.4%-0.2pp | -0.2%-0.0pp | -0.2%-0.2pp | -0.0% |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt-to-Equity | 3.53+0.3 | 3.23+0.3 | 2.94+0.2 | 2.73-1.2 | 3.97+0.1 | 3.82+0.5 | 3.32+0.2 | 3.08 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Frequently Asked Questions
What is CFTZV's annual revenue?
CFTZV (CFTZV) reported $97.9M in total revenue for fiscal year 2025. This represents a 2.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is CFTZV's revenue growing?
CFTZV (CFTZV) revenue grew by 2.4% year-over-year, from $95.5M to $97.9M in fiscal year 2025.
Is CFTZV profitable?
No, CFTZV (CFTZV) reported a net income of -$8.4M in fiscal year 2025, with a net profit margin of -8.6%.
How much debt does CFTZV have?
As of fiscal year 2025, CFTZV (CFTZV) had $25.4M in cash and equivalents against $600.7M in long-term debt.
What is CFTZV's net profit margin?
CFTZV (CFTZV) had a net profit margin of -8.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is CFTZV's return on equity (ROE)?
CFTZV (CFTZV) has a return on equity of -5.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is CFTZV's operating cash flow?
CFTZV (CFTZV) generated $27.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are CFTZV's total assets?
CFTZV (CFTZV) had $1.1B in total assets as of fiscal year 2025, including both current and long-term assets.
What is CFTZV's debt-to-equity ratio?
CFTZV (CFTZV) had a debt-to-equity ratio of 3.53 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is CFTZV's return on assets (ROA)?
CFTZV (CFTZV) had a return on assets of -0.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is CFTZV's Piotroski F-Score?
CFTZV (CFTZV) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are CFTZV's earnings high quality?
CFTZV (CFTZV) has an earnings quality ratio of -3.25x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is CFTZV?
CFTZV (CFTZV) scores 12 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.